HEADER TRANSFERASE 23-JAN-06 2FSL TITLE MITOGEN ACTIVATED PROTEIN KINASE P38ALPHA (D176A+F327S) ACTIVATING TITLE 2 MUTANT FORM-A COMPND MOL_ID: 1; COMPND 2 MOLECULE: MITOGEN-ACTIVATED PROTEIN KINASE 14; COMPND 3 CHAIN: X; COMPND 4 SYNONYM: MITOGEN-ACTIVATED PROTEIN KINASE P38 ALPHA, MAP KINASE P38 COMPND 5 ALPHA, CYTOKINE SUPPRESSIVE ANTI-INFLAMMATORY DRUG BINDING PROTEIN, COMPND 6 CSAID-BINDING PROTEIN, CSBP, MAX-INTERACTING PROTEIN 2, MAP KINASE COMPND 7 MXI2, SAPK2A; COMPND 8 EC: 2.7.1.37; COMPND 9 ENGINEERED: YES; COMPND 10 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 8 EXPRESSION_SYSTEM_PLASMID: PET28 KEYWDS MITOGEN ACTIVATED PROTEIN KINASE, P38, ACTIVE MUTANTS, LIPIDS, MAP KEYWDS 2 KINASE INSERTION, AUTOPHOSPHORYLATION, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR R.DISKIN,O.LIVNAH REVDAT 5 10-NOV-21 2FSL 1 SEQADV HETSYN REVDAT 4 29-JUL-20 2FSL 1 COMPND REMARK SEQADV HETNAM REVDAT 4 2 1 SITE REVDAT 3 24-FEB-09 2FSL 1 VERSN REVDAT 2 12-DEC-06 2FSL 1 JRNL REVDAT 1 05-DEC-06 2FSL 0 JRNL AUTH R.DISKIN,M.LEBENDIKER,D.ENGELBERG,O.LIVNAH JRNL TITL STRUCTURES OF P38ALPHA ACTIVE MUTANTS REVEAL CONFORMATIONAL JRNL TITL 2 CHANGES IN L16 LOOP THAT INDUCE AUTOPHOSPHORYLATION AND JRNL TITL 3 ACTIVATION JRNL REF J.MOL.BIOL. V. 365 66 2007 JRNL REFN ISSN 0022-2836 JRNL PMID 17059827 JRNL DOI 10.1016/J.JMB.2006.08.043 REMARK 2 REMARK 2 RESOLUTION. 1.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.1.24 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 48.80 REMARK 3 DATA CUTOFF (SIGMA(F)) : 1.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 3 NUMBER OF REFLECTIONS : 37426 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.220 REMARK 3 R VALUE (WORKING SET) : 0.219 REMARK 3 FREE R VALUE : 0.240 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1976 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.70 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.75 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2642 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2570 REMARK 3 BIN FREE R VALUE SET COUNT : 149 REMARK 3 BIN FREE R VALUE : 0.2830 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2670 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 20 REMARK 3 SOLVENT ATOMS : 207 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 32.92 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.04000 REMARK 3 B22 (A**2) : 0.00000 REMARK 3 B33 (A**2) : 0.03000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.127 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.116 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.080 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 2.403 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.951 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.948 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2748 ; 0.017 ; 0.021 REMARK 3 BOND LENGTHS OTHERS (A): 2514 ; 0.002 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3726 ; 1.561 ; 1.964 REMARK 3 BOND ANGLES OTHERS (DEGREES): 5856 ; 0.880 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 328 ; 6.929 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): NULL ; NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 423 ; 0.112 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2990 ; 0.009 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 537 ; 0.003 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 575 ; 0.226 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 2808 ; 0.238 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): 1623 ; 0.085 ; 0.200 REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 144 ; 0.182 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 8 ; 0.116 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): 48 ; 0.220 ; 0.200 REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 20 ; 0.156 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1659 ; 1.077 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2688 ; 1.992 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1089 ; 2.726 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1038 ; 4.521 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 2FSL COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 27-JAN-06. REMARK 100 THE DEPOSITION ID IS D_1000036261. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 20-DEC-05 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.2 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID29 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.953 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 39481 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.700 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 200 DATA REDUNDANCY : 14.10 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.07200 REMARK 200 FOR THE DATA SET : 75.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.76 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.2 REMARK 200 DATA REDUNDANCY IN SHELL : 7.70 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.44200 REMARK 200 FOR SHELL : 5.800 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 41.23 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.09 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 18% PEG 3350, 0.2M KF, 0.1 HEPES, 25MM REMARK 280 BOG, PH 7.2, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 34.00050 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 37.24350 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 34.83850 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 37.24350 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 34.00050 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 34.83850 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE BIOLOGICAL ACTIVE UNIT IS A MONOMER REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: X REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET X -6 REMARK 465 ALA X -5 REMARK 465 HIS X -4 REMARK 465 HIS X -3 REMARK 465 HIS X -2 REMARK 465 HIS X -1 REMARK 465 HIS X 0 REMARK 465 HIS X 1 REMARK 465 SER X 2 REMARK 465 GLN X 3 REMARK 465 TYR X 35 REMARK 465 ILE X 116 REMARK 465 VAL X 117 REMARK 465 LYS X 118 REMARK 465 CYS X 119 REMARK 465 PHE X 169 REMARK 465 GLY X 170 REMARK 465 LEU X 171 REMARK 465 ALA X 172 REMARK 465 ARG X 173 REMARK 465 HIS X 174 REMARK 465 THR X 175 REMARK 465 ALA X 176 REMARK 465 ASP X 177 REMARK 465 GLU X 178 REMARK 465 MET X 179 REMARK 465 THR X 180 REMARK 465 GLY X 181 REMARK 465 TYR X 182 REMARK 465 GLN X 355 REMARK 465 GLU X 356 REMARK 465 GLU X 357 REMARK 465 MET X 358 REMARK 465 GLU X 359 REMARK 465 SER X 360 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LEU X 353 CB CG CD1 CD2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OD1 ASN X 201 OG1 THR X 203 1.91 REMARK 500 OE1 GLN X 128 NE2 GLN X 310 2.05 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 MET X 194 CG MET X 194 SD -0.202 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP X 227 CB - CG - OD1 ANGL. DEV. = 5.5 DEGREES REMARK 500 ASP X 230 CB - CG - OD2 ANGL. DEV. = 6.1 DEGREES REMARK 500 ASP X 315 CB - CG - OD2 ANGL. DEV. = 5.6 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER X 32 -84.61 -59.54 REMARK 500 ASN X 100 -30.34 -136.14 REMARK 500 ARG X 149 -10.60 78.29 REMARK 500 ASP X 150 46.55 -143.93 REMARK 500 MET X 198 -171.52 55.12 REMARK 500 PHE X 274 60.27 -108.68 REMARK 500 LEU X 289 61.06 -100.45 REMARK 500 SER X 327 52.88 -63.39 REMARK 500 GLU X 328 -45.24 -179.62 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 VAL X 30 GLY X 31 -149.09 REMARK 500 SER X 327 GLU X 328 -138.56 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2FSM RELATED DB: PDB REMARK 900 RELATED ID: 2FSO RELATED DB: PDB REMARK 900 RELATED ID: 2FST RELATED DB: PDB DBREF 2FSL X 2 360 UNP Q16539 MK14_HUMAN 1 359 SEQADV 2FSL MET X -6 UNP Q16539 EXPRESSION TAG SEQADV 2FSL ALA X -5 UNP Q16539 EXPRESSION TAG SEQADV 2FSL HIS X -4 UNP Q16539 EXPRESSION TAG SEQADV 2FSL HIS X -3 UNP Q16539 EXPRESSION TAG SEQADV 2FSL HIS X -2 UNP Q16539 EXPRESSION TAG SEQADV 2FSL HIS X -1 UNP Q16539 EXPRESSION TAG SEQADV 2FSL HIS X 0 UNP Q16539 EXPRESSION TAG SEQADV 2FSL HIS X 1 UNP Q16539 EXPRESSION TAG SEQADV 2FSL ALA X 176 UNP Q16539 ASP 175 ENGINEERED MUTATION SEQADV 2FSL SER X 327 UNP Q16539 PHE 326 ENGINEERED MUTATION SEQRES 1 X 367 MET ALA HIS HIS HIS HIS HIS HIS SER GLN GLU ARG PRO SEQRES 2 X 367 THR PHE TYR ARG GLN GLU LEU ASN LYS THR ILE TRP GLU SEQRES 3 X 367 VAL PRO GLU ARG TYR GLN ASN LEU SER PRO VAL GLY SER SEQRES 4 X 367 GLY ALA TYR GLY SER VAL CYS ALA ALA PHE ASP THR LYS SEQRES 5 X 367 THR GLY LEU ARG VAL ALA VAL LYS LYS LEU SER ARG PRO SEQRES 6 X 367 PHE GLN SER ILE ILE HIS ALA LYS ARG THR TYR ARG GLU SEQRES 7 X 367 LEU ARG LEU LEU LYS HIS MET LYS HIS GLU ASN VAL ILE SEQRES 8 X 367 GLY LEU LEU ASP VAL PHE THR PRO ALA ARG SER LEU GLU SEQRES 9 X 367 GLU PHE ASN ASP VAL TYR LEU VAL THR HIS LEU MET GLY SEQRES 10 X 367 ALA ASP LEU ASN ASN ILE VAL LYS CYS GLN LYS LEU THR SEQRES 11 X 367 ASP ASP HIS VAL GLN PHE LEU ILE TYR GLN ILE LEU ARG SEQRES 12 X 367 GLY LEU LYS TYR ILE HIS SER ALA ASP ILE ILE HIS ARG SEQRES 13 X 367 ASP LEU LYS PRO SER ASN LEU ALA VAL ASN GLU ASP CYS SEQRES 14 X 367 GLU LEU LYS ILE LEU ASP PHE GLY LEU ALA ARG HIS THR SEQRES 15 X 367 ALA ASP GLU MET THR GLY TYR VAL ALA THR ARG TRP TYR SEQRES 16 X 367 ARG ALA PRO GLU ILE MET LEU ASN TRP MET HIS TYR ASN SEQRES 17 X 367 GLN THR VAL ASP ILE TRP SER VAL GLY CYS ILE MET ALA SEQRES 18 X 367 GLU LEU LEU THR GLY ARG THR LEU PHE PRO GLY THR ASP SEQRES 19 X 367 HIS ILE ASP GLN LEU LYS LEU ILE LEU ARG LEU VAL GLY SEQRES 20 X 367 THR PRO GLY ALA GLU LEU LEU LYS LYS ILE SER SER GLU SEQRES 21 X 367 SER ALA ARG ASN TYR ILE GLN SER LEU THR GLN MET PRO SEQRES 22 X 367 LYS MET ASN PHE ALA ASN VAL PHE ILE GLY ALA ASN PRO SEQRES 23 X 367 LEU ALA VAL ASP LEU LEU GLU LYS MET LEU VAL LEU ASP SEQRES 24 X 367 SER ASP LYS ARG ILE THR ALA ALA GLN ALA LEU ALA HIS SEQRES 25 X 367 ALA TYR PHE ALA GLN TYR HIS ASP PRO ASP ASP GLU PRO SEQRES 26 X 367 VAL ALA ASP PRO TYR ASP GLN SER SER GLU SER ARG ASP SEQRES 27 X 367 LEU LEU ILE ASP GLU TRP LYS SER LEU THR TYR ASP GLU SEQRES 28 X 367 VAL ILE SER PHE VAL PRO PRO PRO LEU ASP GLN GLU GLU SEQRES 29 X 367 MET GLU SER HET BOG X1000 20 HETNAM BOG OCTYL BETA-D-GLUCOPYRANOSIDE HETSYN BOG BETA-OCTYLGLUCOSIDE; OCTYL BETA-D-GLUCOSIDE; OCTYL D- HETSYN 2 BOG GLUCOSIDE; OCTYL GLUCOSIDE FORMUL 2 BOG C14 H28 O6 FORMUL 3 HOH *207(H2 O) HELIX 1 1 SER X 61 MET X 78 1 18 HELIX 2 2 SER X 95 PHE X 99 5 5 HELIX 3 3 THR X 123 ALA X 144 1 22 HELIX 4 4 LYS X 152 SER X 154 5 3 HELIX 5 5 ALA X 190 LEU X 195 1 6 HELIX 6 6 THR X 203 GLY X 219 1 17 HELIX 7 7 ASP X 227 GLY X 240 1 14 HELIX 8 8 GLY X 243 LYS X 248 1 6 HELIX 9 9 SER X 252 SER X 261 1 10 HELIX 10 10 ASN X 269 VAL X 273 5 5 HELIX 11 11 ASN X 278 LEU X 289 1 12 HELIX 12 12 ASP X 292 ARG X 296 5 5 HELIX 13 13 THR X 298 ALA X 304 1 7 HELIX 14 14 HIS X 305 ALA X 309 5 5 HELIX 15 15 ASP X 313 GLU X 317 5 5 HELIX 16 16 LEU X 333 PHE X 348 1 16 SHEET 1 A 2 PHE X 8 LEU X 13 0 SHEET 2 A 2 THR X 16 PRO X 21 -1 O THR X 16 N LEU X 13 SHEET 1 B 5 TYR X 24 PRO X 29 0 SHEET 2 B 5 SER X 37 ASP X 43 -1 O ALA X 40 N SER X 28 SHEET 3 B 5 LEU X 48 LYS X 54 -1 O LEU X 48 N ASP X 43 SHEET 4 B 5 TYR X 103 HIS X 107 -1 O LEU X 104 N LYS X 53 SHEET 5 B 5 ASP X 88 PHE X 90 -1 N ASP X 88 O VAL X 105 SHEET 1 C 3 ALA X 111 ASP X 112 0 SHEET 2 C 3 LEU X 156 VAL X 158 -1 O VAL X 158 N ALA X 111 SHEET 3 C 3 LEU X 164 ILE X 166 -1 O LYS X 165 N ALA X 157 CRYST1 68.001 69.677 74.487 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014706 0.000000 0.000000 0.00000 SCALE2 0.000000 0.014352 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013425 0.00000